Skip to main content

Advertisement

SpringerLink
Log in

Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

The incidence of thyroid cancer is increasing and the proliferation of thyroid cancer cells is incompletely understood. microRNAs may play key roles in thyroid cancer progression.

Methods

We analyzed miR-340-5p in thyroid cancer tissue and normal tissue, and using informatics to predict its target. Cell lines and a mouse model were used to study the role of miR-340-5p in cancer proliferation.

Results

Overexpression of miR-340-5p was found in thyroid cancer specimens. Tumors with higher pathological grade had higher levels of miR-340-5p. Overexpression of miR-340-5p significantly enhanced cell viability and colony formation. Treatment of anti-miR-340-5p, however, showed opposite alterations. We predicted that bone morphogenetic protein 4 (BMP4) is a possible target, and found a negative correlation between miR-340-5p and BMP4 levels in thyroid cancer tissue. miR-340-5p reduced BMP4 expression. BMP4 overexpression attenuated the effects of miR-340-5p in cell viability and colony formation. In addition, using a xenograft mouse model we proved that anti-miR-340-5p was able to inhibit tumor growth.

Conclusions

miR-340-5p promotes thyroid cancer proliferation by inhibiting BMP4. Anti-miR-340-5p can be a promising strategy to control thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387

    Article  Google Scholar 

  2. Fagin JA, Wells SA Jr (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375:1054–1067. https://doi.org/10.1056/NEJMra1501993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lai EC (2015) Two decades of miRNA biology: lessons and challenges. RNA 21:675–677. https://doi.org/10.1261/rna.051193.115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Blenkiron C, Miska EA (2007) miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 16(Spec No 1):R106–R113. https://doi.org/10.1093/hmg/ddm056

    Article  CAS  PubMed  Google Scholar 

  5. de la Chapelle A, Jazdzewski K (2011) MicroRNAs in thyroid cancer. J Clin Endocrinol Metab 96:3326–3336. https://doi.org/10.1210/jc.2011-1004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Xiong Q, Wu S, Wang J, Zeng X, Chen J, Wei M, Guan H, Fan C, Chen L, Guo D, Sun G (2017) Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci 7:16. https://doi.org/10.1186/s13578-017-0144-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Song L, Duan P, Gan Y, Li P, Zhao C, Xu J, Zhang Z, Zhou Q (2017) MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATbeta in osteosarcoma. Braz J Med Biol Res 50:e6359. https://doi.org/10.1590/1414-431X20176359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wozniak M, Sztiller-Sikorska M, Czyz M (2015) Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions. Exp Mol Pathol 99:707–716. https://doi.org/10.1016/j.yexmp.2015.11.014

    Article  CAS  PubMed  Google Scholar 

  9. Zhang Q, Lou Y, Zhang J, Fu Q, Wei T, Sun X, Chen Q, Yang J, Bai X, Liang T (2017) Hypoxia-inducible factor-2alpha promotes tumor progression and has crosstalk with Wnt/beta-catenin signaling in pancreatic cancer. Mol Cancer 16:119. https://doi.org/10.1186/s12943-017-0689-5

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Munoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, Haura EB (2016) ZEB1 mediates acquired resistance to the epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer. PLoS ONE 11:e0147344. https://doi.org/10.1371/journal.pone.0147344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gao H, Teng C, Huang W, Peng J, Wang C (2015) SOX2 promotes the epithelial to mesenchymal transition of esophageal squamous cells by modulating slug expression through the activation of STAT3/HIF-alpha signaling. Int J Mol Sci 16:21643–21657. https://doi.org/10.3390/ijms160921643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo LL, Chen HL, Zhang GY, Deng LL (2013) Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 43:113–120. https://doi.org/10.3892/ijo.2013.1913

    Article  CAS  PubMed  Google Scholar 

  13. Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM (2007) Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Arch Otolaryngol Head Neck Surg 133:1022–1027. https://doi.org/10.1001/archotol.133.10.1022

    Article  PubMed  Google Scholar 

  14. Mitra A, Mishra L, Li S (2015) EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 6:10697–10711. https://doi.org/10.18632/oncotarget.4037

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zhou Y, Tong L, Chu X, Deng F, Tang J, Tang Y, Dai Y (2017) The adenosine A1 receptor antagonist DPCPX inhibits tumor progression via the ERK/JNK pathway in renal cell carcinoma. Cell Physiol Biochem 43:733–742. https://doi.org/10.1159/000481557

    Article  CAS  PubMed  Google Scholar 

  16. Zhu J, Wang FL, Wang HB, Dong N, Zhu XM, Wu Y, Wang YT, Yao YM (2017) TNF-alpha mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein. Sci Rep 7:12239. https://doi.org/10.1038/s41598-017-12492-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Czajka AA, Wojcicka A, Kubiak A, Kotlarek M, Bakula-Zalewska E, Koperski L, Wiechno W, Jazdzewski K (2016) Family of microRNA-146 regulates RARbeta in papillary thyroid carcinoma. PLoS ONE 11:e0151968. https://doi.org/10.1371/journal.pone.0151968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ampuja M, Jokimaki R, Juuti-Uusitalo K, Rodriguez-Martinez A, Alarmo EL, Kallioniemi A (2013) BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 13:429. https://doi.org/10.1186/1471-2407-13-429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, Chuu CP, Chen CY, Hsiung CA, Chang JY, Wang LH, Chang IS, Jiang SS (2014) Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Int J Cancer 135:809–819. https://doi.org/10.1002/ijc.28734

    Article  CAS  PubMed  Google Scholar 

  20. Shirai YT, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K (2011) Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol 179:2920–2930. https://doi.org/10.1016/j.ajpath.2011.08.022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Reddy KB (2015) MicroRNA (miRNA) in cancer. Cancer Cell Int 15:38. https://doi.org/10.1186/s12935-015-0185-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Duerr EM, Mizukami Y, Moriichi K, Gala M, Jo WS, Kikuchi H, Xavier RJ, Chung DC (2012) Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines. Am J Physiol Gastrointest Liver Physiol 302:G1223–G1230. https://doi.org/10.1152/ajpgi.00047.2011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Meng X, Zhu P, Li N, Hu J, Wang S, Pang S, Wang J (2017) Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression. Pathol Res Pract 213:359–363. https://doi.org/10.1016/j.prp.2017.01.008

    Article  CAS  PubMed  Google Scholar 

  24. Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203–222. https://doi.org/10.1038/nrd.2016.246

    Article  CAS  PubMed  Google Scholar 

  25. Bai XL, Zhang Q, Ye LY, Liang F, Sun X, Chen Y, Hu QD, Fu QH, Su W, Chen Z, Zhuang ZP, Liang TB (2015) Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/beta-catenin signaling. Oncogene 34:4089–4097. https://doi.org/10.1038/onc.2014.337

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, 050017, Hebei, China

    P. Zhao, W. Ma, Z. Hu, Y. Zhang & Y. Wang

  2. Xingtai People’s Hospital of Hebei Province, No. 16 Hongxing Street, Xingtai, 054031, Hebei, China

    S. Zhang

Authors
  1. P. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Informed consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, P., Ma, W., Hu, Z. et al. Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4. J Endocrinol Invest 41, 1165–1172 (2018). https://doi.org/10.1007/s40618-018-0848-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0848-6

Keywords

Search

Navigation